Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies-Reference-Cited by-同舟云学术

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies

Published:2014-12-08 Issue: Volume:4 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

De Veirman Kim,Van Valckenborgh Els,Lahmar Qods,Geeraerts Xenia,De Bruyne Elke,Menu Eline,Van Riet Ivan,Vanderkerken Karin,Van Ginderachter Jo A.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference105 articles.

1. Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells;Han;J Cell Mol Med,2011

2. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells;Bianchi;Histol Histopathol,2011

3. Immunosuppressive strategies that are mediated by tumor cells;Rabinovich;Annu Rev Immunol,2007

4. Instruction of myeloid cells by the tumor microenvironment: open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations;Schouppe;Oncoimmunology,2012

5. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity;Movahedi;Blood,2008

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived Suppressor Cells and Multiple Sclerosis;Current Neuropharmacology;2024-07-10

2. Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia;Haematologica;2024-05-10

3. Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value;Blood Science;2023-10

4. Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy;Expert Review of Anticancer Therapy;2023-06-27

5. Attempt to assess direct interactions between tumor burden, myeloid-derived suppressor cells and PD-1- and TIM-3-expressing T cells in multiple myeloma patients;Medical Immunology (Russia);2023-06-01